Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria
- Institution
- EVELIQURE BIOTECHNOLOGIES, GMBH
- Principal investigator
- Frank Malinowski
- Funding
- $4.7M
- Duration
- 2020–2027
Moonbase score
Still being scored
Abstract
To support the advanced development of a candidate vaccine for resistant bacteria. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in animal models, IND enabling GLP toxicology, submission of an IND and clinical safety and efficacy evaluation. This project includes a Phase 2 clinical trial.
LOADING MOONBASE SCORE
Questions for Eveliqure Biotechnologies, Gmbh
Eveliqure Biotechnologies, Gmbh hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same topic, scored first.
- NIH · Immunartes LlcNot yet scored
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
Vilasack Thammavongsa · $211K · 2022–2027
- NIH · Duke UniversityNot yet scored
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
Kevin Saunders · $99K · 2022–2026
- NIH · Intravacc B.V.Not yet scored
Advanced Development of Vaccine Candidates for Biodefense and Emerging Antibiotic-Resistant Infectious Diseases
Corine Kruiswijk · $1.2M · 2022–2026